(E)-3-(2,3-dichloro-phenyl)-2-methyl-acrylic acid | 399579-98-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)-3-(2,3-dichloro-phenyl)-2-methyl-acrylic acid
• 英文别名: (E)-3-(2,3-dichlorophenyl)-2-methylprop-2-enoic acid
• CAS: 399579-98-7
• 化学式: C₁₀H₈Cl₂O₂
• 分子量: 231.078
• InChiKey: HXZNSCOGFKQQCY-AATRIKPKSA-N

物化性质

• 沸点：
  364.8±32.0 °C(Predicted)
• 密度：
  1.398±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  三乙基2-膦酰基丙酯 、 2,3-二氯苯甲醛 在 sodium hydroxide 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 0.5h， 以72%的产率得到(E)-3-(2,3-dichloro-phenyl)-2-methyl-acrylic acid
  参考文献：
  名称：

  [EN] ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF
  [FR] DERIVES D'ACRYLAMIDE SERVANT D'ANTAGONISTES DE L'INTEGRINE VLA-1, ET LEURS UTILISATIONS

  摘要：

  公开号：

  WO2005016883A3

文献信息

• INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS
  申请人：SMITHKLINE BEECHAM PLC

  公开号：EP1309551A1

  公开（公告）日：2003-05-14
• [EN] INDOLINE DERIVATIVES AS 5HT2C ANTAGONISTS<br/>[FR] DERIVES D'INDOLINE EN TANT QU'ANTAGONISTES 5HT2C
  申请人：SMITHKLINE BEECHAM PLC

  公开号：WO2002014273A1

  公开（公告）日：2002-02-21

  The invention relates to novel cinnamide compounds which have 5-HT2C antagonist activity and have the general formula (I), or is a pharmaceutically acceptable salt thereof: in which P is phenyl or naphthyl; R1 is halogen, C¿1-6?alkyl, C1-6alkoxy, C1-6alkylthio, hydroxy, amino, mono- or di-C1-6alkylamino, nitro, CN, CF3, OCF3, aryl, arylC1-6alkyl, arylC1-6alkyloxy or arylC1-6alkylthio; a is 0, 1, 2, 3, 4 or 5; R?2 and R3¿ are independently hydrogen or C¿1-6?alkyl; R?4¿ is hydrogen, halogen, C¿1-6?alkyl, C1-6alkocy, aryl, cyano, haloC1-6alkyl or OCF3; Z is carbon or nitrogen; R?5¿ is either: (i) a group NR6R7 where R?6 and R7¿ are independently hydrogen, optionally substituted C¿1-6?alkyl; or (ii) an optionally substituted N-linked heterocycle; or (iii) an optionally substituted C-linked heterocycle; n is 0, 1, 2 or 3 subject to the proviso that n is not 0 when R?5¿ is a group (i) or (ii); --- represents a single or double bond; X and Y are independently CR8R9 (when --- represents a single bond) or X and Y are independently CR10 (when --- represents a double bond) wherein R?8, R9 and R10¿ are independently hydrogen or C¿1-6?alkyl. Also disclosed are processes for their preparation, compositions containing them and their use in the treatment of CNS and other disorders.
• [EN] ACRYLAMIDE DERIVATIVES AS VLA-1 INTEGRIN ANTAGONISTS AND USES THEREOF<br/>[FR] DERIVES D'ACRYLAMIDE SERVANT D'ANTAGONISTES DE L'INTEGRINE VLA-1, ET LEURS UTILISATIONS
  申请人：ICOS CORP

  公开号：WO2005016883A3

  公开（公告）日：2005-04-14